Given the high rate of gastrointestinal tolerability challenges and resultant discontinuation that is characteristic of GLP-1 therapy, we believe that a personalized approach to GLP-1 titration and dosing, including a mealtime bolus option, would give patients an opportunity to reach their treatment goals, while experiencing easier therapy initiation and a more tolerable maintenance regimen, said Jeb Besser, CEO of Modular Medical.
Vercoutre B, Durozard D, Baverel G, Martin G
Ipamorelin is a growth hormone-releasing peptide (GHRP)
Glutathione: its implications for animal health, meat quality, and health benefits of consumers
Always consult a doctor for approval before taking any supplements